Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug compound characterization by mass spectrometry imaging in cancer tissue.
Kwon HJ, Kim Y, Sugihara Y, Baldetorp B, Welinder C, Watanabe K, Nishimura T, Malm J, Török S, Döme B, Végvári Á, Gustavsson L, Fehniger TE, Marko-Varga G. Kwon HJ, et al. Among authors: sugihara y. Arch Pharm Res. 2015 Sep;38(9):1718-27. doi: 10.1007/s12272-015-0627-2. Epub 2015 Jul 23. Arch Pharm Res. 2015. PMID: 26198812 Review.
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C, Pawłowski K, Szasz AM, Yakovleva M, Sugihara Y, Malm J, Jönsson G, Ingvar C, Lundgren L, Baldetorp B, Olsson H, Rezeli M, Laurell T, Wieslander E, Marko-Varga G. Welinder C, et al. Among authors: sugihara y. PLoS One. 2017 Apr 26;12(4):e0176167. doi: 10.1371/journal.pone.0176167. eCollection 2017. PLoS One. 2017. PMID: 28445515 Free PMC article.
Clinical protein science in translational medicine targeting malignant melanoma.
Gil J, Betancourt LH, Pla I, Sanchez A, Appelqvist R, Miliotis T, Kuras M, Oskolas H, Kim Y, Horvath Z, Eriksson J, Berge E, Burestedt E, Jönsson G, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Horvatovich P, Murillo JR, Sugihara Y, Welinder C, Wieslander E, Lee B, Lindberg H, Pawłowski K, Kwon HJ, Doma V, Timar J, Karpati S, Szasz AM, Németh IB, Nishimura T, Corthals G, Rezeli M, Knudsen B, Malm J, Marko-Varga G. Gil J, et al. Among authors: sugihara y. Cell Biol Toxicol. 2019 Aug;35(4):293-332. doi: 10.1007/s10565-019-09468-6. Epub 2019 Mar 21. Cell Biol Toxicol. 2019. PMID: 30900145 Free PMC article.
A protein deep sequencing evaluation of metastatic melanoma tissues.
Welinder C, Pawłowski K, Sugihara Y, Yakovleva M, Jönsson G, Ingvar C, Lundgren L, Baldetorp B, Olsson H, Rezeli M, Jansson B, Laurell T, Fehniger T, Döme B, Malm J, Wieslander E, Nishimura T, Marko-Varga G. Welinder C, et al. Among authors: sugihara y. PLoS One. 2015 Apr 13;10(4):e0123661. doi: 10.1371/journal.pone.0123661. eCollection 2015. PLoS One. 2015. PMID: 25874936 Free PMC article.
Novel insights in drug metabolism by MS imaging.
Sugihara Y, Watanabe K, Végvári Á. Sugihara Y, et al. Bioanalysis. 2016 Mar;8(6):575-88. doi: 10.4155/bio-2015-0020. Epub 2016 Feb 26. Bioanalysis. 2016. PMID: 26915978 Review.
Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors.
Torok S, Rezeli M, Kelemen O, Vegvari A, Watanabe K, Sugihara Y, Tisza A, Marton T, Kovacs I, Tovari J, Laszlo V, Helbich TH, Hegedus B, Klikovits T, Hoda MA, Klepetko W, Paku S, Marko-Varga G, Dome B. Torok S, et al. Among authors: sugihara y. Theranostics. 2017 Jan 1;7(2):400-412. doi: 10.7150/thno.16767. eCollection 2017. Theranostics. 2017. PMID: 28042343 Free PMC article.
266 results